InvestorsHub Logo
Followers 155
Posts 2647
Boards Moderated 0
Alias Born 01/29/2004

Re: scottsmith post# 83173

Saturday, 12/10/2016 4:13:34 PM

Saturday, December 10, 2016 4:13:34 PM

Post# of 462643
"...scientists do understand it but are too biased to give it respect?"


No, they understand it completely. Nothing mysterious about Anavex 2-73. It's just different from anything they ever imagined might work against the neuron deficiencies that underly the root cause(s)of Alzheimer's.

After spending years and years in the lab striving for useful applications and efficacies of the approaches one has believed in, Anavex's revolutionary approach requires a complete re-thinking of the solutions to the Alzheimer's problem.

Medicine has historically been confounded by this sort of thing. It took many decades for conventional, highly-regarded medical people to believe Pasteur and Lister and Semmelweis that "germs" actually caused disease.

As with the antibiotic revolution in the late 1940s, modern physicians will much more quickly embrace an Anevex understanding and treatment of Alzheimer's and other CNS diseases. The clinical data (as they were with antibiotics) will be too overwhelming to discount.

We (and they) have just seen the first of those affirming data. Lots more to come, I'm certain.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News